On the heels of a year that saw a record amount of venture cash flow into healthcare startups, investor appetite for healthtech does not appear to be waning.
While clinical trials can take years, in a matter of weeks this Stanford lab identified a drug that could help in the fight against COVID-19. Though it is unlikely a silver bullet, this lab is on the cutting edge of a significant trend in artificial in…
Our second annual list highlights promising, private, U.S.-based companies that are using artificial intelligence in meaningful business-oriented ways.